Skip to main content
. Author manuscript; available in PMC: 2024 Jan 21.
Published in final edited form as: Lancet. 2022 Dec 20;401(10372):215–225. doi: 10.1016/S0140-6736(22)02079-7

Table 1.

Characteristics of participants in the training/validation set.

Characteristic All participants (N=20,497) CAD controls (N=17,828) CAD cases (n=2,669)
Median age (IQR) — years 62 (19) 61 (18) 72 (16)
Sex — no. (%)
 Female 12,470 (61) 11,110 (62) 1,360 (51)
 Male 8,027 (39) 6,718 (38) 1,309 (49)
Ethnicity — no. (%)
 African 5,480 (27) 4,755 (27) 725 (27)
 European 5,887 (29) 5,276 (30) 611 (23)
 Hispanic 7,424 (36) 6,276 (35) 1,148 (43)
 Other 1,704 (8.3) 1,519 (8.5) 185 (6.9)
Ever smoked — no. (%) 3,830 (19) 3,308 (19) 522 (20)
Median vitals (IQR)
 Weight — lbs 172 (53) 170 (55) 180 (37)
 Height — inches 65 (5.1) 65 (5.0) 66 (5.3)
 Systolic blood pressure — mmHg 128 (17) 127 (18) 133 (9.7)
 Diastolic blood pressure — mmHg 73 (10) 74 (11) 72 (6)
 Pulse — sec−1 77 (12) 77 (12) 75 (11)
 Oxygen saturation — % on room air 98 (1.0) 98 (1.5) 97 (0.72)
 Respirations — min−1 18 (1.0) 18 (1.1) 18 (0.52)
 Temperature — °F 98 (0.55) 98 (0.60) 98 (0.21)
Median laboratory measurement (IQR)
 Low-density lipoprotein cholesterol — mg/dL 100 (35) 101 (34) 90 (31)
 High-density lipoprotein cholesterol — mg/dL 53 (19) 54 (19) 48 (17)
 Triglycerides — mg/dL 115 (67) 114 (67) 124 (65)
 Glucose — mg/dL 92 (22) 91 (20) 103 (43)
 Hemoglobin A1c — % 5.7 (0.80) 5.7 (0.73) 5.1 (1.5)
 Troponin-I — ng/dL 0.011 (0.040) 0.010 (0.035) 0.023 (0.13)
 Lactate dehydrogenase — U/L 213 (44) 211 (42) 224 (53)
 Erythrocyte sedimentation rate — mm/hr 22 (24) 21 (23) 33 (27)
Comorbidities — no. (%)
 Hypercholesterolemia 10,748 (52) 8,506 (48) 2,207 (83)
 Hypertension 11,762 (57) 9,376 (53) 2,365 (89)
 Type 2 diabetes 6,395 (31) 4,834 (27) 1,529 (57)

IQR, interquartile range; no., number; ethnicity, self-reported ethnicity; other, other miscellaneous ethnicities besides the ones listed.